The study analyzed 973,520 cases of metabolic and bariatric surgery, revealing that conditions such as GERD, COPD, smoking, and specific surgical procedures significantly heighten the risk of inpatient postoperative care (IP-POC) needs. Male patients exhibited increased severity but lower likelihood of complications, while Black and Hispanic patients faced higher risks. Scoring thresholds for IP-POC have […]

A meta-analysis of ten randomized controlled trials demonstrated that Roux-en-Y gastric bypass (RYGB) significantly enhances outcomes for patients with type 2 diabetes mellitus (T2DM). Key findings revealed improved compliance rates, higher remission rates, and reductions in glycated hemoglobin (HbA1c) and fasting blood glucose levels. Additionally, participants experienced substantial weight loss, better lipid profiles, and lower […]

In a study comparing weight loss outcomes between sleeve gastrectomy (SG) and semaglutide in a minority population, SG demonstrated superior weight loss after 12 months. The cohort, primarily consisting of African American (67%) and Hispanic (21%) patients with a mean BMI of 55 kg/m², included 206 participants. Results indicated that semaglutide may be less effective […]

Histological remission of metabolic dysfunction-associated steatohepatitis (MASH) and significant fibrosis enhances survival rates post-bariatric surgery. In a cohort of 3028 patients over a median follow-up of 10.1 years, those with persistent MASH or worsening fibrosis exhibited increased mortality, while those whose MASH resolved without fibrosis worsening showed no increased risk. Survival was significantly prolonged in […]

A meta-analysis revealed that sleeve gastrectomy (SG) significantly reduces the apnea-hypopnea index (AHI), body mass index (BMI), weight, and fat areas while enhancing forced vital capacity (FVC) and sleep metrics in patients with obesity and obstructive sleep apnea (OSA). Key post-surgical benefits included decreased arousal index, oxygen desaturation index (ODI), and improvements in metabolic markers […]

In adults with morbid obesity, sleeve gastrectomy (SG) significantly lowers all-cause mortality risks during follow-up compared to Roux-en-Y gastric bypass (RYGB). A systematic review and meta-analysis of 22 studies involving 333,713 patients revealed that SG is linked to reduced reoperation, reintervention, and hospitalization rates, although it has a higher revision rate. These findings underscore the […]

Healthcare professionals and patient representatives have reached a consensus on safe practices for bariatric and metabolic surgery tourism (BMT) in Europe. Key recommendations emphasize the importance of pre-operative evaluations, management of psychological health, and regulatory standards like surgeon accreditation. With input from 119 healthcare professionals and 88 patient representatives across 26 countries, the consensus aims […]

Sleeve gastrectomy has shown profound benefits for metabolic health in a cohort of 199 patients, revealing significant reductions in weight, BMI, and abdominal circumference. Notable improvements in diabetic patients included decreases in fasting blood sugar and glycosylated hemoglobin levels, alongside a marked reduction in insulin resistance and serum insulin. Additionally, enhancements in lipid profiles and […]

Surgical techniques during laparoscopic sleeve gastrectomy significantly affect the development of gastroesophageal reflux disease (GERD). Analyzing 7,435 patients, the study found that using a narrower bougie size and resecting further from the pylorus increased the likelihood of requiring proton pump inhibitors (PPIs) post-surgery. Advanced age and female sex were identified as independent risk factors for […]